![PDF) Multi-Stakeholder Governance for Effectively Sharing Social Responsibility (Social Contracts, Deliberative Democracy and Endogenous Conformity) | Lorenzo Sacconi - Academia.edu PDF) Multi-Stakeholder Governance for Effectively Sharing Social Responsibility (Social Contracts, Deliberative Democracy and Endogenous Conformity) | Lorenzo Sacconi - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/50358212/mini_magick20190129-14857-ne7ops.png?1548776708)
PDF) Multi-Stakeholder Governance for Effectively Sharing Social Responsibility (Social Contracts, Deliberative Democracy and Endogenous Conformity) | Lorenzo Sacconi - Academia.edu
![Surface Decomposition of Doped PrBaMn2O5+δ Induced by In Situ Nanoparticle Exsolution: Quantitative Characterization and Catalytic Effect in Methane Dry Reforming Reaction | Chemistry of Materials Surface Decomposition of Doped PrBaMn2O5+δ Induced by In Situ Nanoparticle Exsolution: Quantitative Characterization and Catalytic Effect in Methane Dry Reforming Reaction | Chemistry of Materials](https://pubs.acs.org/cms/10.1021/acs.chemmater.2c02488/asset/images/medium/cm2c02488_0004.gif)
Surface Decomposition of Doped PrBaMn2O5+δ Induced by In Situ Nanoparticle Exsolution: Quantitative Characterization and Catalytic Effect in Methane Dry Reforming Reaction | Chemistry of Materials
![Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) - The Lancet Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) - The Lancet](https://www.thelancet.com/cms/attachment/6e7c64fd-e6a8-47d8-ac46-cb9c37ef8dd7/gr1_lrg.jpg)
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) - The Lancet
![PDF) Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): An open-label, randomised, phase 3 trial PDF) Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): An open-label, randomised, phase 3 trial](https://i1.rgstatic.net/publication/276358091_Efficacy_of_neoadjuvant_bevacizumab_added_to_docetaxel_followed_by_fluorouracil_epirubicin_and_cyclophosphamide_for_women_with_HER2-negative_early_breast_cancer_ARTemis_An_open-label_randomised_phase_/links/561ebf4f08aec7945a26ff47/largepreview.png)
PDF) Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): An open-label, randomised, phase 3 trial
![Surface Decomposition of Doped PrBaMn2O5+δ Induced by In Situ Nanoparticle Exsolution: Quantitative Characterization and Catalytic Effect in Methane Dry Reforming Reaction | Chemistry of Materials Surface Decomposition of Doped PrBaMn2O5+δ Induced by In Situ Nanoparticle Exsolution: Quantitative Characterization and Catalytic Effect in Methane Dry Reforming Reaction | Chemistry of Materials](https://pubs.acs.org/cms/10.1021/acs.chemmater.2c02488/asset/images/large/cm2c02488_0008.jpeg)